Recent advances in Clostridium difficiIe-associated disease

Monaghan, T.; Boswell, T.; Mahida, Y. H.
June 2008
Gut;Jun2008, Vol. 57 Issue 6, p850
Academic Journal
The main purpose of this article is to review recent developments in the management of acute and recurrent Clostridium difficile-associated disease, with consideration of existing and new antibiotic and non-antibiotic agents for treatment. Details of the current developmental stage of new agents are provided and the role of surgery in the management of severe disease is discussed. Infection control measures considered comprise prudent use of antimicrobials, prevention of cross-infection and surveillance. Other topics that are covered include the recent emergence of an epidemic hypervirulent strain, pathogenesis, clinical presentation and approaches to rapid diagnosis and assessment of the colonic disease.


Related Articles

  • OPTIMIZING THE USE OF Carbapenems IN THE FACE OF INCREASING GRAM-NEGATIVE RESISTANCE.  // Formulary;Jul2007 Supplement, Vol. 42, p3 

    The article focuses on the clinical and economic impact of carbapenems, an antibiotic with a broad spectrum of antibacterial activity, in the U.S. The drug possesses a broad spectrum of activity that threatens the superinfections by fungi and resistant bacteria including the collateral damage in...

  • Collective action and individual choice: rethinking how we regulate narcotics and antibiotics. Anomaly, Jonny // Journal of Medical Ethics;Dec2013, Vol. 39 Issue 12, p752 

    Governments across the globe have squandered treasure and imprisoned millions of their own citizens by criminalising the use and sale of recreational drugs. But use of these drugs has remained relatively constant, and the primary victims are the users themselves. Meanwhile, antimicrobial drugs...

  • Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model. Yakob, Laith; Riley, Thomas V.; Paterson, David L.; Clements, Archie C. A. // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: Clostridium difficile is the leading cause of infectious diarrhea in hospitalized patients. Its epidemiology has shifted in recent years from almost exclusively infecting elderly patients in whom the gut microbiota has been disturbed by antimicrobials, to now also infecting...

  • A staff nurse's perspective of infection control problems. Grainger, Michelle // British Journal of Nursing;9/22/2005, Vol. 14 Issue 17, p912 

    Earlier this month astonishing figures causing major concern were released from the Department of Health (DoH) showing the number of cases of Clostridium difficile in the over 65s in hospitals in England. This article focuses upon what is already known about infection control and concludes that...

  • A case-control study of community-associated Clostridium difficile infection. M. H. Wilcox; L. Mooney; R. Bendall; C. D. Settle; W. N. Fawley // Journal of Antimicrobial Chemotherapy (JAC);Aug2008, Vol. 62 Issue 2, p388 

    Objectives The aim of this study was to determine the incidence of and risk factors for community-associated Clostridium difficile infection (CDI). Methods Prospective surveillance of community-derived faecal samples for C. difficile cytotoxin, followed by a questionnaire-based...

  • Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. Werner, Nicole L.; Hecker, Michelle T.; Sethi, Ajay K.; Donskey, Curtis J. // BMC Infectious Diseases;2011, Vol. 11 Issue 1, p187 

    Background: Fluoroquinolones are among the most commonly prescribed antimicrobials and are an important risk factor for colonization and infection with fluoroquinolone-resistant gram-negative bacilli and for Clostridium difficile infection (CDI). In this study, our aim was to determine current...

  • Treat Clostridium difficile infection based on its severity and number of previous episodes.  // Drugs & Therapy Perspectives;Feb2012, Vol. 28 Issue 2, p10 

    The article reports on medical problems, including colitis and diarrhea, which can occur as a result of clostridium difficile infections, and discusses the challenges that are associated with properly treating the infections. A discussion of various antibacterial therapies which are suitable for...

  • The New Clostridium difficile – What Does It Mean? Bartlett, John G.; Perl, Trish M. // New England Journal of Medicine;12/8/2005, Vol. 353 Issue 23, p2503 

    The article presents information about the pathogen Clostridium difficile, which causes disease almost exclusively in the presence of exposure to antibiotics. C. difficile colonizes about 3 percent of healthy adults and 20 to 40 percent of hospitalized patients, while it is found in...

  • Way Too Much of a Good Thing... STEVE SOLOMON, M. D. Barr, Paul // H&HN: Hospitals & Health Networks;Nov2013, Vol. 87 Issue 11, p36 

    The article presents an interview with Steve Solomon, the director of the Office of Antimicrobial Resistance at the U.S. Centers for Disease Control and Prevention (CDC). When asked about a growing epidemic of antimicrobial resistance in the U.S., Solomon says the problem has existed since the...


Read the Article


Sign out of this library

Other Topics